Menu Button
About Us
Approach
Lead program
Clinical strategy
Tauopathies
News
Press Releases/News
All
2019
October 31, 2019
Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody that Targets a Potent Driver of Neurodegenerative Disease
October 31, 2019
Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody that Targets a Potent Driver of Neurodegenerative Disease
About Us
Approach
Lead program
Clinical strategy
Tauopathies
News
